Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

enthalten in: Annals of oncology | 2016

von Gillessen, S. | Omlin, A. | Attard, G. | +41

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

enthalten in: Annals of oncology | 2015

von Gillessen, S. | Omlin, A. | Attard, G. | +41

Management of patients with advanced prostate cancer: Recommendations of the St.Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

enthalten in: Annals of oncology | 2015

von Gillessen, S. | Omlin, A. | Attard, G. | +41

Reply to the letter to the editor 'Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al

enthalten in: Annals of oncology | 2015

von Gillessen, S. | Fanti, S. | Omlin, A.

ESMO-EANM-ESR - Imaging biomarkers in the era of targeted therapies

enthalten in: Annals of oncology | 2012

von Bogaerts, J. | Menu, Y. | Graser, A. | +2

A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma

enthalten in: Annals of oncology | 2012

von Zinzani, P. | Tani, M. | Pulsoni, A. | +17

Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer

enthalten in: Annals of oncology | 2011

von Martoni, A. | Di Fabio, F. | Pinto, C. | +11

FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study

enthalten in: Annals of oncology | 2010

von Lopci, E. | Santi, I. | Derenzini, E. | +9

MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients

enthalten in: Annals of oncology | 2010

von Derenzini, E. | Fina, M. | Stefoni, V. | +11

A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients

enthalten in: Annals of oncology | 2008

von Zinzani, P. | Tani, M. | Fanti, S. | +13